Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Clin Res Cardiol

Search In Journal Title:

Abbravation: Clinical Research in Cardiology

Search In Journal Abbravation:

Publisher

Springer Berlin Heidelberg

Search In Publisher:

DOI

10.1007/bf00299322

Search In DOI:

ISSN

1861-0692

Search In ISSN:
Search In Title Of Papers:

Procedural safety of a fully implantable intraveno

Authors: Manuel J Richter Ralf Ewert Christian Warnke Henning Gall Simon Classen Friedrich Grimminger Eckhard Mayer Werner Seeger HosseinArdeschir Ghofrani
Publish Date: 2016/09/26
Volume: 106, Issue: 3, Pages: 174-182
PDF Link

Abstract

In patients with severe pulmonary arterial hypertension subcutaneous or catheterbased intravenous application of prostanoids carries a risk of local side effects or systemic infections which limits their use and acceptance Recently a fully implantable pump for continuous application of intravenous treprostinil was approved in Germany However surgery is a major risk for patients with severe pulmonary arterial hypertension The purpose of this study was to investigate the safety of a fully implantable pump inserted under local or general anesthesia in patients with severe pulmonary hypertensionAll patients with pulmonary hypertension undergoing pump implantation for the continuous application of intravenous treprostinil were included from two German centers Surgery was performed under local or general anesthesia according to the protocol of the recruiting center Intraoperative safety and inhospital complications were analyzed for the two different implantation regimensIn total 51 patients were included No major intraoperative complications were recorded During the observation period two patients died of progressive right heart failure and two patients required treatment in the intensive care unit for acute right heart decompensation and respiratory failure In total major complications occurred in 8 out of 51 patientsOur observational study provides preliminary evidence supporting the procedural safety of a fully implantable pump inserted under local or general anesthesia for patients with severe pulmonary hypertension The observation of major complications in a subset of patients requires extensive pre and postoperative assessments Future trials are required to provide further evidence for the longterm safety and efficacy of the pump using this approachEditorial assistance was provided by Adelphi Communications Ltd Bollington UK at the request of the authors This study was supported by a publication grant from United Therapeutics MJR has received support from United Therapeutics and Bayer Pharma AG and speaker fees from Actelion Mundipharma Roche and OMT RE has received research grants from Actelion and speaker fees from Bayer Pharma AG GlaxoSmithKline Pfizer Encysive and AstraZeneca HG has received support and/or honoraria from Actelion AstraZeneca Bayer Pharma AG GlaxoSmithKline Janssen Cilag Lilly Pfizer and United Therapeutics/OMT WS has received speaker/consultancy fees from Pfizer and Bayer Pharma AG FG has received research grants from Bayer Pharma AG Pfizer Ergonex and Encysive honoraria from Bayer Pharma AG Pfizer Actelion Encysive and Novartis and has been a paid consultant for Nycomed Altana Pharma HAG has received fees from Actelion Bayer Pharma AG Gilead GSK Lilly Lung Rx Merck Novartis and Pfizer The other authors have no relevant relationships to disclose


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Management of percutaneous self-expanding bioprosthesis migration
  2. IMPROV-ED study: outcomes after discharge for an episode of acute-decompensated heart failure and comparison between patients discharged from the emergency department and hospital wards
  3. Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions
  4. Efficacy of extracorporeal membrane oxygenation in a congenital heart surgery program
  5. A TASH experience: post-infarction myocardial oedema necessitating the support of ECMO and occurrence of significant mitral regurgitation
  6. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter
  7. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group
  8. A comparative evaluation of electrical velocimetry and inert gas rebreathing for the non-invasive assessment of cardiac output
  9. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy
  10. In-hospital outcomes after elective and non-elective percutaneous coronary interventions in hospitals with and without on-site cardiac surgery backup
  11. Pathophysiologie der chronischen Herzinsuffizienz
  12. Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study
  13. Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation
  14. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model
  15. Radial artery applanation tonometry for continuous noninvasive arterial blood pressure monitoring in the cardiac intensive care unit
  16. Impending paradoxical thromboembolism: thrombus caught in transit. A case report
  17. Pickering syndrome: high-risk stenting of a renal artery stenosis in a multimorbid patient presenting with progressive congestive heart failure
  18. Diagnostic performance of magnetic resonance first pass perfusion imaging is equally potent in female compared to male patients with coronary artery disease
  19. Atrial fibrillation—
  20. Molecular evidence of Enterococcus faecalis in an occluding coronary thrombus from a patient with late prosthetic valve endocarditis
  21. Effizienz und Effektivität von Prävention
  22. Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
  23. Hydroxychloroquine-induced cardiomyopathy in a patient with limited cutaneous systemic sclerosis
  24. Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension
  25. Managing difficult anatomy: remote-controlled ablation of atrioventricular nodal reentry tachycardia in a patient with agenesis of the inferior vena cava

Search Result: